BIOMAT Database Logo BIOMAT Database Logo

The effects of antigenic competition on the efficacy of multivalent footrot vaccines. 1993

C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Arthur Webster Pty Ltd., Baulkham Hills, New South Wales.

A multivalent footrot vaccine has been developed, containing pilus antigens produced in recombinant Pseudomonas aeruginosa and representing all nine serogroups of Dichelobacter (Bacteroides) nodosus commonly recognised in the field. The responses of sheep to the multivalent vaccine have been compared with those to monovalent vaccines representing only a single serogroup. Antigenic competition between serogroups occurred in sheep immunised with the multivalent formation, but high levels of protection were still achieved. The study showed that in multivalent footrot vaccines, antigenic competition is predominantly due to the presence of a family of immunologically-related pilus antigens rather than to interference by extraneous proteins.

UI MeSH Term Description Entries
D008297 Male Males
D010861 Fimbriae, Bacterial Thin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein (pilin) in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins (ADHESINS, BACTERIAL). Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of "pili", which is confined to sex pili (PILI, SEX). Bacterial Fimbriae,Bacterial Pili,Common Fimbriae,Common Pili,Pili, Bacterial,Pili, Common,Bacterial Fimbria,Bacterial Pilus,Common Fimbria,Common Pilus,Fimbria, Bacterial,Pilus, Bacterial,Fimbria, Common,Fimbriae, Common,Pilus, Common
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D005260 Female Females
D005535 Foot Rot A disease of the horny parts and of the adjacent soft structures of the feet of cattle, swine, and sheep. It is usually caused by Corynebacterium pyogenes or Bacteroides nodosus (see DICHELOBACTER NODOSUS). It is also known as interdigital necrobacillosis. (From Black's Veterinary Dictionary, 18th ed) Foot Rots,Rot, Foot,Rots, Foot
D000372 Agglutination Tests Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed) Agglutination Test,Test, Agglutination,Tests, Agglutination
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial

Related Publications

C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Immunological parameters associated with antigenic competition in a multivalent footrot vaccine.
December 1995, Vaccine,
C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Modulation of inter-vaccination interval to avoid antigenic competition in multivalent footrot (Dichelobacter nodosus) vaccines in sheep.
December 2009, Vaccine,
C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Antigenic competition in a multivalent foot rot vaccine.
April 1994, Vaccine,
C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Antigenic competition following reconstitution of canine vaccines.
July 1991, Australian veterinary journal,
C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Footrot vaccines and vaccination.
May 2014, Vaccine,
C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Studies on antigenic competition. 3. Effect on antigenic competition on antibody affinity.
May 1974, Immunology,
C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Recombinant vaccines against ovine footrot.
October 1993, Immunology and cell biology,
C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Effects of antigenic competition on immune responses to tumors.
January 1976, Annals of the New York Academy of Sciences,
C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Studies on antigenic competition.
October 1969, The Journal of experimental medicine,
C L Schwartzkoff, and J R Egerton, and D J Stewart, and P R Lehrbach, and T C Elleman, and P A Hoyne
Manipulation of the helper T cell response to influence antigenic competition occurring with a multivalent vaccine.
February 1996, Immunology and cell biology,
Copied contents to your clipboard!